Cookies on this site

The University of Oxford has been awarded €8 million through the European Union’s Horizon Europe programme to coordinate the development of the Pandemics AI Observatory (PANDAI). Led by the University in partnership with the World Health Organization and an international consortium of leading research, public health and technology partners, the three-year project will develop and deploy advanced artificial intelligence (AI) models to transform the detection, assessment, prediction and response to global infectious disease threats.

Participants group photo © John Cairns

Recent outbreaks of mpox, avian influenza, dengue, and Ebola have highlighted the need for faster, more integrated approaches to disease detection and response. Public health agencies have access to vast amounts of data, but much of it is fragmented and difficult to analyse quickly. 

‘Public health authorities already have access to enormous amounts of information, but the challenge is turning that information into reliable intelligence quickly enough to make a difference,’ said Professor Richard Maude, Principal Investigator of PANDAI, Professor of Tropical Medicine at the Nuffield Department of Medicine and Head of Epidemiology at the Mahidol Oxford Tropical Medicine Research Unit (MORU). 

‘PANDAI will use AI to bring together diverse sources of data, assess what emerging threats mean for different places and populations, predict how they may develop, and provide the evidence needed to make faster and better-informed public health decisions.’

The World Health Organization (WHO) Health Security Division/Europe will define what the system needs to do and how it should be structured, and will ensure that the PANDAI platform integrates smoothly with existing frameworks, such as the Epidemic Intelligence from Open Sources (EIOS) initiative. The WHO will also ensure the system can be used by national ministries of health and global policymakers.

Dr Marc-Alain Widdowson, World Health Organization European Region said ‘This initiative will make a real difference to how the public health community can act on data, by bringing together far more sources and perspectives than we've had access to before. By building on existing WHO systems and expanding use of AI, we'll be able to pick out and prioritise the most important signals faster, build a fuller picture of the risk, and quickly recommend the right control measures for the situation at hand serving member states.’

At the core of the Observatory is the creation of a cutting-edge AI model, one of the first epidemiology-informed domain-specific foundation models (EDFMs) for infectious disease surveillance and epidemic intelligence. It will integrate disease surveillance, environmental, health system, veterinary, preparedness capacity, mobility and pathogen genomic data to provide experts/public health authorities with AI-driven insights. 

Professor Melinda Mills, co-investigator from Oxford Population Health said ‘PANDAI brings together data on population behaviour, mobility, health systems and demographics to better understand how diseases spread and how people respond. By focusing on strong communication, integrating behavioural social science, attention to diversity and stakeholder perspectives into AI models from the outset, we can build tools that are not only more accurate, but also more equitable, trusted and useful for public health decision-making.’

The PANDAI platform will undergo rigorous, multi-country validation across three distinct transmission pathways: vector-borne arboviruses (such as dengue and West Nile virus), respiratory viruses (exemplified by seasonal and novel avian/swine influenza strains like H5N1), and direct-contact infections (mpox). This will help ensure that the platform's framework can be generalised to future emerging infectious disease threats, including the unknown "Disease X”. 

Public health officials will be able to conduct secure "what-if" simulations, assessing the real-world impact of interventions, such as localised lockdowns or prioritised vaccination schedules, prior to field deployment.

The project will also address the ethical and legal challenges of using AI for public health surveillance, with measures to protect privacy, minimise the use of personal data and reduce the risk of bias. A compliance work package, led by the Luxembourg National Data Services, will institute protocols and assessments to mitigate algorithmic bias while ensuring compliance with the EU AI Act, proving that pioneering AI innovation can seamlessly coexist with robust data privacy protections.

PANDAI consortium partners

The PANDAI project brings together nine partner organisations spanning public health, artificial intelligence, data science, technology, governance, and civil society across seven countries:

• University of Oxford (United Kingdom) – Coordinator
• World Health Organization (Copenhagen)
• International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) (Bangladesh)
• Clalit Health Services (Israel)
• Bahia Software SLU (Spain)

• Technovative Solutions Ltd (United Kingdom)
• Arteevo Technologies Ltd (Israel)
• Luxembourg National Data Services (PNED GIE) (Luxembourg)
• Infectious Disease Alliance (Denmark)

Similar stories

Salum Mshamu named a 2026 TIME Trailblazer

Congratulations to Salum Mshamu on being selected as one of TIME’s inaugural 2026 Trailblazers: Designing and Making the Future. A University of Oxford DPhil student, Salum was recognised for his contribution to research showing how improved housing design can reduce malaria and other childhood illnesses.

Behind the Title: Becoming an Oxford Professor (at NDM): Featuring Professor Direk Limmathurotsakul

The Behind the Title: Becoming an Oxford Professor (at NDM) series highlights the diverse journeys of our professors and the many paths that lead to academic leadership. By sharing their journeys we aim to showcase the breadth of backgrounds, disciplines, and experiences represented across the Department, demonstrating that there is no single route to becoming a professor at Oxford.

MODRA Cohort 1: Where they are now and what comes next?

Eighteen months after joining MODRA, our first fellows are leading projects, winning grants, and building new collaborations across the region. Upon completion of the MODRA programme and moving move into the next stage of their careers, here’s a look at how our fellows are turning learning into lasting impact.

Professor Direk Limmathurotsakul awarded 2026 UNESCO-Carlos J. Finlay Prize for Microbiology

Professor Direk Limmathurotsakul has received the 2026 UNESCO-Carlos J. Finlay Prize for Microbiology. The Prize recognises his contributions to microbiology, particularly his work on melioidosis, antimicrobial-resistant (AMR) infections and turning local data into public health action.

MORU research highlighted during The Princess Royal’s visit to Mahidol University

A film featuring melioidosis survivors and a tour of a MORU malaria laboratory highlighted how patient-centred research and laboratory capacity contribute to regional health security.

Mahidol University and Thai Health Tech Association Sign Agreement to Strengthen Health Innovation and Research Translation

Mahidol University’s Faculty of Tropical Medicine, the Mahidol Oxford Tropical Medicine Research Unit (MORU), and the Thai Health Tech Association (THTA) signed a Memorandum of Understanding (MoU) to strengthen collaboration on health innovation, translational research, and capacity development, with the aim of advancing the translation of research into practical health technologies.

Similar stories

Salum Mshamu named a 2026 TIME Trailblazer

Congratulations to Salum Mshamu on being selected as one of TIME’s inaugural 2026 Trailblazers: Designing and Making the Future. A University of Oxford DPhil student, Salum was recognised for his contribution to research showing how improved housing design can reduce malaria and other childhood illnesses.

Behind the Title: Becoming an Oxford Professor (at NDM): Featuring Professor Direk Limmathurotsakul

The Behind the Title: Becoming an Oxford Professor (at NDM) series highlights the diverse journeys of our professors and the many paths that lead to academic leadership. By sharing their journeys we aim to showcase the breadth of backgrounds, disciplines, and experiences represented across the Department, demonstrating that there is no single route to becoming a professor at Oxford.

MODRA Cohort 1: Where they are now and what comes next?

Eighteen months after joining MODRA, our first fellows are leading projects, winning grants, and building new collaborations across the region. Upon completion of the MODRA programme and moving move into the next stage of their careers, here’s a look at how our fellows are turning learning into lasting impact.

Professor Direk Limmathurotsakul awarded 2026 UNESCO-Carlos J. Finlay Prize for Microbiology

Professor Direk Limmathurotsakul has received the 2026 UNESCO-Carlos J. Finlay Prize for Microbiology. The Prize recognises his contributions to microbiology, particularly his work on melioidosis, antimicrobial-resistant (AMR) infections and turning local data into public health action.

MORU research highlighted during The Princess Royal’s visit to Mahidol University

A film featuring melioidosis survivors and a tour of a MORU malaria laboratory highlighted how patient-centred research and laboratory capacity contribute to regional health security.

Mahidol University and Thai Health Tech Association Sign Agreement to Strengthen Health Innovation and Research Translation

Mahidol University’s Faculty of Tropical Medicine, the Mahidol Oxford Tropical Medicine Research Unit (MORU), and the Thai Health Tech Association (THTA) signed a Memorandum of Understanding (MoU) to strengthen collaboration on health innovation, translational research, and capacity development, with the aim of advancing the translation of research into practical health technologies.